| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.7M | — | +1026.7% |
| Cost of Revenue | $5.1M | — | +919.9% |
| Gross Profit | $1.6M | — | +1598.8% |
| R&D Expense | $57K | — | +560.5% |
| SG&A Expense | $2.4M | — | +126.1% |
| Operating Income | -$854K | — | +11.6% |
| Net Income | -$1.2M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $890K | +12.0% | +126.2% |
| Accounts Receivable | $5.2M | +74.6% | +167.1% |
| Inventory | $1.5M | -30.8% | -16.3% |
| Current Assets | $8.4M | +25.4% | +101.4% |
| Total Assets | $8.4M | +24.1% | +103.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.5M | — | -320.6% |
| Financing Cash Flow | $2.6M | — | — |
| -28.9% |
| EPS (Basic) | -$0.04 | — | -33.3% |
| EPS (Diluted) | -$0.04 | — | -33.3% |
| $5.7M |
| +61.7% |
| +2138.3% |
| Total Liabilities | $6.3M | +62.1% | — |
| Stockholders' Equity | $2.1M | -26.7% | -45.3% |